Search
for
Sort by
Research 601–630 of 864
- The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
- Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor Modulators
- Androgen sensitivity gateway to COVID‐19 disease severity
- Impact of estrogens in males and androgens in females
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Endocrine intervention for transsexuals
- Epidermal stem cells and skin tissue engineering in hair follicle regeneration
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- Intracrinology and The Skin
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Safety of testosterone treatment in postmenopausal women
- Sex hormones and acne
- Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
- Hirsutism
- <i>Saccharomyces cerevisiae</i> BLYAS, a New Bioluminescent Bioreporter for Detection of Androgenic Compounds
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- 3α-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats
- Male sex hormones, aging, and inflammation
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Characteristics of Androgenetic Alopecia in Asian
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model